NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. [electronic resource]
- Leukemia 07 2017
- 1648-1650 p. digital
Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1476-5551
10.1038/leu.2017.115 doi
Bone and Bones--metabolism Cell Differentiation--physiology Glucuronidase--metabolism Humans Multiple Myeloma--metabolism NIMA-Related Kinases--metabolism Osteoclasts--pathology